Source: Annual Congress 2013 –COPD: new markers of diseases
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
N. Rana, B. Barker, K. Haldar, H. Patel, V. Mistry, M. Pancholi, M. Barer, C. Brightling, M. Bafadhel (Leicester, United Kingdom). Association between qPCR bacterial load and airway inflammation in COPD. Eur Respir J 2013; 42: Suppl. 57, 598

Member's Comments

No comment yet.

Related content which might interest you: Relationship between COPD characteristics and airway bacterial load measured using 16S qPCR Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 The relationship between blood eosinophils and bacterial load in COPD patients Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Comparison of quantitative PCR and quantitative culture for the detection of airway pathogenic bacteria in COPD Source: International Congress 2014 – Markers Year: 2014 The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Quantitative analysis of potentially pathogenic microbes (PPMs) in the induced sputum of non-smoker COPD (NS-COPD) subjects Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients Year: 2016 Bacterial load is associated with neutrophilic sputum in severe asthmatics Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 The species-specific inflammatory response of colonising bacteria in stable COPD Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Association between airway bacterial abundance and urinary inflammatory biomarkers in COPD Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Alterations of the soluble proteome of airway epithelial cells in COPD Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013 Airway glucose in COPD exacerbations Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients Year: 2016 Association between bacterial load and inflammatory gene expression in COPD exacerbations Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 PTX3 a marker of innate immune responses in the airways of asthmatics and COPD patients Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 Identification of causative bacteria in the airways of COPD by a novel semi-quantitative PCR method Source: Annual Congress 2013 –COPD and infections Year: 2013 Analysis of the microbiota of sputum samples from patients with chronic obstructive pulmonary disease Source: International Congress 2014 – COPD exacerbations Year: 2014 Dynamics of sputum antimicrobial peptide levels in chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance Year: 2015 Modulation of inflammation by benralizumab in eosinophilic airway disease Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Presence of progranulin in airway inflammation associated with COPD Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease Source: International Congress 2014 – Cell biology 2014 Year: 2014